Nxera Pharma Notes Successful Development Progress of Partnered Schizophrenia Candidate NBI-1117568
16. April 2024 02:30 ET
|
Nxera Pharma
NBI-1117568 is an oral, selective muscarinic M4 receptor agonist advancing through Phase 2 clinical development under a multi-program collaboration with Neurocrine BiosciencesSuccessful completion of...
Athira Pharma Doses First Subject in Phase 1 Clinical Trial of HGF/MET Positive Modulator, ATH-1020, an Orally Available Small Molecule for Neuropsychiatric Conditions
04. April 2022 07:00 ET
|
Athira Pharma, Inc.
BOTHELL, Wash., April 04, 2022 (GLOBE NEWSWIRE) -- Athira Pharma, Inc. (NASDAQ: ATHA), a late clinical-stage biopharmaceutical company focused on developing small molecules to restore neuronal...
Praxis Precision Medicines to Present at Citi’s 16th Annual BioPharma Virtual Conference
01. September 2021 09:00 ET
|
Praxis Precision Medicines, Inc.
CAMBRIDGE, Mass., Sept. 01, 2021 (GLOBE NEWSWIRE) -- Praxis Precision Medicines, Inc. (NASDAQ: PRAX), a clinical-stage biopharmaceutical company translating genetic insights into the development of...
Six Outstanding Mental Health Researchers Honored by the Brain & Behavior Research Foundation
04. August 2021 10:00 ET
|
Brain & Behavior Research Foundation
New York, Aug. 04, 2021 (GLOBE NEWSWIRE) -- The Brain & Behavior Research Foundation (BBRF) has announced the winners of its 2021 Klerman and Freedman Prizes, which recognize exceptional...
Praxis Precision Medicines to Present at Upcoming Investor Conferences
06. Juli 2021 09:00 ET
|
Praxis Precision Medicines, Inc.
CAMBRIDGE, Mass., July 06, 2021 (GLOBE NEWSWIRE) -- Praxis Precision Medicines, Inc. (NASDAQ: PRAX), a clinical-stage biopharmaceutical company translating genetic insights into the development of...
Dr. Stephen I. Kramer Appointed to American Health Council’s Board of Physicians
06. September 2017 08:00 ET
|
American Health Council
NEW YORK, Sept. 06, 2017 (GLOBE NEWSWIRE) -- Dr. Stephen I. Kramer, Professor Emeritus at Wake Forest Baptist Health Sciences and Field Representative/Physician Surveyor at The Joint Commission, has...
American Health Council Names Michael Irwin, M.D. to Physician Board
06. Dezember 2016 13:00 ET
|
American Health Council
NEW YORK, Dec. 06, 2016 (GLOBE NEWSWIRE) -- Dr. Michael Irwin, Director and Cousins Distinguished Professor of Psychiatry at UCLA Medical Center, has been selected to join the Physician Board...
American Health Council Names Neil Kaye, MD, DFAPA to Physician Board
29. November 2016 10:00 ET
|
American Health Council
NEW YORK, Nov. 29, 2016 (GLOBE NEWSWIRE) -- Dr. Neil Kaye, Forensic Psychiatrist, has been selected to join the Physician Board at the American Health Council. He will be sharing his knowledge and...